© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Sidharth Chhibbar to join in spring
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad

More articles/Ad

More articles

  • Europcar is one of the first large companies to restructure with a big state-backed Covid-19 rescue loan in its capital structure. The planned scheme, proposed to creditors last week, leaves the guaranteed loan untouched, which is likely to be the preferred plan for future creditor compacts.
  • A group of Suriname’s bondholders said they plan to support the government’s bid for a temporary debt standstill after the sovereign amended a consent solicitation to incorporate some of their requests.
  • ABS
    Hertz is returning to the ABS market for the first time since it filed for bankruptcy in March. The rental car company is revving up for a $4bn delayed draw securitization, a stepping stone towards longer-term ABS deals it hopes to issue next year, sources said.
  • Jacobio Pharmaceuticals is preparing to launch the roadshow for its Hong Kong IPO after winning approval to list from the city’ stock exchange last week.
  • China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing.
  • Having entered default on Thursday, November 26 as the 30-day grace period on a missed coupon payment expired, Suriname has improved the terms on a consent solicitation that — if accepted by at least three quarters of bondholders — would allow it to escape the default and buy time for a more comprehensive debt restructuring.